These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 29960217)

  • 1. Brand name to generic substitution of levetiracetam in patients with epilepsy.
    Gha-Hyun L; Dae SJ
    Seizure; 2018 Aug; 60():127-131. PubMed ID: 29960217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Overnight Switch from Brand-Name to Generic Levetiracetam.
    Vari MS; Pinto F; Mencaroni E; Giudizioso G; Minetti C; La Neve A; Francavilla T; Piccioli M; Striano S; del Gaudio L; Tovo P; Striano P; Verrotti A
    Clin Drug Investig; 2016 Jan; 36(1):87-91. PubMed ID: 26507620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of switching from brand-name to generic levetiracetam in patients with epilepsy.
    Bosak M; Słowik A; Turaj W
    Drug Des Devel Ther; 2017; 11():2287-2291. PubMed ID: 28814836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.
    Markoula S; Chatzistefanidis D; Gatzonis S; Siatouni A; Siarava E; Verentzioti A; Kyritsis AP; Patsalos PN
    Seizure; 2017 May; 48():1-6. PubMed ID: 28363098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizure risk in brain tumor patients with conversion to generic levetiracetam.
    Armstrong TS; Choi S; Walker J; Gilbert MR
    J Neurooncol; 2010 May; 98(1):137-41. PubMed ID: 19936624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with generic levetiracetam in people with epilepsy.
    Chaluvadi S; Chiang S; Tran L; Goldsmith CE; Friedman DE
    Epilepsia; 2011 Apr; 52(4):810-5. PubMed ID: 21426334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of generic substitution on levetiracetam serum concentration-A prospective study in an outpatient setting.
    Reimers A; Olsson P; Nilsson J; Hoff E; Reis M; Strandberg M; Lundgren A; Källén K
    Epilepsy Res; 2017 Aug; 134():54-61. PubMed ID: 28595756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life after switching to generic levetiracetam - A prospective comparative study.
    Olsson P; Reimers A; Källén K
    Epilepsy Behav; 2019 Jul; 96():169-174. PubMed ID: 31150996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic substitution of levetiracetam resulting in increased incidence of breakthrough seizures.
    Fitzgerald CL; Jacobson MP
    Ann Pharmacother; 2011 May; 45(5):e27. PubMed ID: 21521860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
    Contin M; Alberghini L; Candela C; Benini G; Riva R
    Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies.
    Yamada M; Welty TE
    Ann Pharmacother; 2011 Nov; 45(11):1406-15. PubMed ID: 22028417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study.
    Polard E; Nowak E; Happe A; Biraben A; Oger E;
    Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1161-9. PubMed ID: 26395769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy.
    Makus KG; McCormick J
    Clin Ther; 2007 Feb; 29(2):334-41. PubMed ID: 17472825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brand-to-generic levetiracetam switching: a 4-year prospective observational real-life study.
    Trimboli M; Russo E; Mumoli L; Tripepi G; Fortunato F; Mastroianni G; Abate F; De Sarro G; Gambardella A; Labate A
    Eur J Neurol; 2018 Apr; 25(4):666-671. PubMed ID: 29322654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are generic drugs really inferior medicines?
    Moore N; Berdaï D; Bégaud B
    Clin Pharmacol Ther; 2010 Sep; 88(3):302-4. PubMed ID: 20725079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between switching antiepileptic drug products and healthcare utilization: A systematic review.
    Kwan P; Palmini A
    Epilepsy Behav; 2017 Aug; 73():166-172. PubMed ID: 28641169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
    Fong JK; Chan EL; Leung H; Chan I; Chang RS; Fong GC; Fung EL; Lui CH; Fung BB; Poon TL; Siu D; Wong HT; Yeung E; Yung AW; Zhu CX;
    Hong Kong Med J; 2017 Feb; 23(1):74-88. PubMed ID: 28184017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy.
    Erickson SC; Le L; Ramsey SD; Solow BK; Zakharyan A; Stockl KM; Harada AS; Curtis B
    Epilepsia; 2011 Jul; 52(7):1365-71. PubMed ID: 21692778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
    Holtkamp M; Theodore WH
    Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
    Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.